Ann: FDA agrees on potential regulatory pathway f, page-7

re: Ann: FDA agrees on potential regulatory p... Not sure if I have missed something but what is the status with the current (t315i mutation) nda? Both commentary and graph seem to indicate nothing - have FDA given any indication of what needs to be done with that to get approval? Or is it a dead duck and all the focus is now on multi tki avenue.

Any thoughts appreciated.